Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab

NCT03992729 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnancy Related

Interventions

DRUG: Pregnant women exposed to tildrakizumab
DRUG: Pregnant women not exposed to tildrakizumab

Sponsor

Sun Pharmaceutical Industries Limited